Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Molecules ; 27(21)2022 Oct 29.
Article in English | MEDLINE | ID: mdl-36364181

ABSTRACT

The separation and detection of flavonoids from various natural products have attracted increasing attention in the field of natural product research and development. Depending on the high specificity of molecularly imprinted polymers (MIPs), MIPs are proposed as efficient adsorbents for the selective extraction and separation of flavonoids from complex samples. At present, a comprehensive review article to summarize the separation and purification of flavonoids using molecular imprinting, and the employment of MIP-based sensors for the detection of flavonoids is still lacking. Here, we reviewed the general preparation methods of MIPs towards flavonoids, including bulk polymerization, precipitation polymerization, surface imprinting and emulsion polymerization. Additionally, a variety of applications of MIPs towards flavonoids are summarized, such as the different forms of MIP-based solid phase extraction (SPE) for the separation of flavonoids, and the MIP-based sensors for the detection of flavonoids. Finally, we discussed the advantages and disadvantages of the current synthetic methods for preparing MIPs of flavonoids and prospected the approaches for detecting flavonoids in the future. The purpose of this review is to provide helpful suggestions for the novel preparation methods of MIPs for the extraction of flavonoids and emerging applications of MIPs for the detection of flavonoids from natural products and biological samples.


Subject(s)
Biological Products , Molecular Imprinting , Flavonoids , Molecularly Imprinted Polymers , Polymers , Molecular Imprinting/methods , Solid Phase Extraction/methods
2.
NPJ Vaccines ; 7(1): 134, 2022 Oct 31.
Article in English | MEDLINE | ID: mdl-36316367

ABSTRACT

In vaccinology, a potent immunogen has two prerequisite attributes-antigenicity and immunogenicity. We have rational designed a triple-type HPV vaccine against HPV58, -33 and -52 covered in Gardasil 9 based on the sequence homology and similar surface loop structure of L1 protein, which is related to cross-type antigenicity. Here, we design another triple-type vaccine against non-vaccine types HPV39, -68 and -70 by immunogenicity optimization considering type specific immunodominant epitopes located in separate region for different types. First, we optimized the expression of wild-type HPV39, -68 and -70 L1-only virus-like particles (VLPs) in E. coli through N-terminal truncation of HPV L1 proteins and non-fusion soluble expression. Second, based on genetic relationships and an L1 homologous loop-swapping rationale, we constructed several triple-type chimeric VLPs for HPV39, -68 and -70, and obtained the lead candidate named H39-68FG-70DE by the immunogenicity optimization using reactivity profile of a panel type-specific monoclonal antibodies. Through comprehensive characterization using various biochemical, VLP-based analyses and immune assays, we show that H39-68FG-70DE assumes similar particulate properties as that of its parental VLPs, along with comparable neutralization immunogenicity for all three HPV types. Overall, this study shows the promise and translatability of an HPV39/68/70 triple-type vaccine, and the possibility of expanding the type-coverage of current HPV vaccines. Our study further expanded the essential criteria on the rational design of a cross-type vaccine, i.e. separate sites with inter-type similar sequence and structure as well as type-specific immunodominant epitope to be clustered together.

3.
Obes Surg ; 32(9): 2869-2879, 2022 09.
Article in English | MEDLINE | ID: mdl-35729447

ABSTRACT

BACKGROUND: Obesity has become a noticeable public health problem, especially in the young population. Bariatric surgery is growing in China but it is still new to the general public. Knowledge and attitudes towards obesity and bariatric surgery in university students are important to national health decision-making. OBJECTIVES: To study the knowledge and attitudes towards obesity and bariatric surgery among Chinese university students. METHODS: A self-designed questionnaire was distributed to university students to fill in online from June to July 2021. RESULTS: A total of 3199 questionnaires were received, with an effective rate of 98.58% (3154 questionnaires). 65.44% of whom had normal BMI and 12.14% of whom were overweight or in obesity. More than 80% of them had a high knowledge of the common causes and complications of obesity but lacked knowledge of the relationship between obesity and bone and joint, tumor or cancer, and reproductive diseases. 51.55% of them thought they needed to lose weight, especially female students (P < 0.01). Only 39% had regular physical exercise habits, 58.62% of them could reasonably control their diet, and more than 2/3 of them (67.82%) often stayed up late. Safety (29.77%) and effectiveness (29.3%) of bariatric surgery were not well accepted. Among medical students, education positively affected knowledge and attitudes towards bariatric surgery (P < 0.05). Mass media and social platforms were the main sources for obtaining obesity and weight-loss information. CONCLUSIONS: Chinese university students have insufficient knowledge of obesity and related complications, lack of scientific management of their own weight, and poor acceptance of bariatric surgery. More education is needed on this issue.


Subject(s)
Bariatric Surgery , Obesity, Morbid , Students, Medical , Female , Health Knowledge, Attitudes, Practice , Humans , Obesity/surgery , Obesity, Morbid/surgery , Surveys and Questionnaires , Universities
4.
Dis Markers ; 2022: 8605621, 2022.
Article in English | MEDLINE | ID: mdl-35756489

ABSTRACT

Dendritic cells (DC) initiate the immune response in the body. They can stimulate T cell activation, proliferation, and differentiation and ultimately participate in the immune response and the immune tolerance response. The purpose of this study was to coculture DCs and T cells and subcutaneously inject DCs transfected with miR-let-7i into rhesus monkey transplantations to verify the role of miR-let-7i in allograft immune tolerance. In vitro studies found that the expression of miR-let-7i was upregulated after inducing the maturation of DCs. The low expression of miR-let-7i inhibited the maturation of DCs, promoted the differentiation of T cells into T helper T cells 2 (Th2), and inhibited T helper T cell 1- (Th1-) driven rejection. In vivo studies also obtained similar results, and subcutaneous injection of DCs transfected with miR-let-7i inhibitor prolonged the survival time of allogeneic skin transplantation. Therefore, we conclude that inhibition of miR-let-7i inhibits DC maturation and improves the tolerance of grafted skin.


Subject(s)
Dendritic Cells , MicroRNAs , Skin Transplantation , T-Lymphocytes , Cell Differentiation/immunology , Dendritic Cells/immunology , Humans , Immune Tolerance , MicroRNAs/antagonists & inhibitors , MicroRNAs/immunology , T-Lymphocytes/immunology , Transplantation Immunology
5.
IEEE Trans Pattern Anal Mach Intell ; 44(10): 6981-6992, 2022 10.
Article in English | MEDLINE | ID: mdl-34283712

ABSTRACT

This paper addresses the problem of reconstructing 3D poses of multiple people from a few calibrated camera views. The main challenge of this problem is to find the cross-view correspondences among noisy and incomplete 2D pose predictions. Most previous methods address this challenge by directly reasoning in 3D using a pictorial structure model, which is inefficient due to the huge state space. We propose a fast and robust approach to solve this problem. Our key idea is to use a multi-way matching algorithm to cluster the detected 2D poses in all views. Each resulting cluster encodes 2D poses of the same person across different views and consistent correspondences across the keypoints, from which the 3D pose of each person can be effectively inferred. The proposed convex optimization based multi-way matching algorithm is efficient and robust against missing and false detections, without knowing the number of people in the scene. Moreover, we propose to combine geometric and appearance cues for cross-view matching. Finally, an efficient tracking method is proposed to track the detected 3D poses across the multi-view video. The proposed approach achieves the state-of-the-art performance on the Campus and Shelf datasets, while being efficient for real-time applications.


Subject(s)
Algorithms , Imaging, Three-Dimensional , Humans , Imaging, Three-Dimensional/methods
6.
Nat Commun ; 11(1): 2841, 2020 06 05.
Article in English | MEDLINE | ID: mdl-32503989

ABSTRACT

The capsid of human papillomavirus (HPV) spontaneously arranges into a T = 7 icosahedral particle with 72 L1 pentameric capsomeres associating via disulfide bonds between Cys175 and Cys428. Here, we design a capsomere-hybrid virus-like particle (chVLP) to accommodate multiple types of L1 pentamers by the reciprocal assembly of single C175A and C428A L1 mutants, either of which alone encumbers L1 pentamer particle self-assembly. We show that co-assembly between any pair of C175A and C428A mutants across at least nine HPV genotypes occurs at a preferred equal molar stoichiometry, irrespective of the type or number of L1 sequences. A nine-valent chVLP vaccine-formed through the structural clustering of HPV epitopes-confers neutralization titers that are comparable with that of Gardasil 9 and elicits minor cross-neutralizing antibodies against some heterologous HPV types. These findings may pave the way for a new vaccine design that targets multiple pathogenic variants or cancer cells bearing diverse neoantigens.


Subject(s)
Capsid Proteins/immunology , Neoplasms/therapy , Papillomaviridae/immunology , Papillomavirus Infections/therapy , Papillomavirus Vaccines/immunology , Animals , Antibodies, Neutralizing/blood , Antibodies, Neutralizing/immunology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Capsid Proteins/administration & dosage , Capsid Proteins/genetics , Drug Design , Epitopes/genetics , Epitopes/immunology , Female , Humans , Immunogenicity, Vaccine , Mice , Models, Animal , Mutation , Neoplasms/virology , Neutralization Tests , Papillomaviridae/genetics , Papillomavirus Infections/virology , Papillomavirus Vaccines/administration & dosage , Papillomavirus Vaccines/genetics , Protein Multimerization/genetics , Protein Multimerization/immunology , Vaccines, Virus-Like Particle/administration & dosage , Vaccines, Virus-Like Particle/genetics , Vaccines, Virus-Like Particle/immunology
7.
Nat Commun ; 9(1): 5360, 2018 12 18.
Article in English | MEDLINE | ID: mdl-30560935

ABSTRACT

Sequence variability in surface-antigenic sites of pathogenic proteins is an important obstacle in vaccine development. Over 200 distinct genomic sequences have been identified for human papillomavirus (HPV), of which more than 18 are associated with cervical cancer. Here, based on the high structural similarity of L1 surface loops within a group of phylogenetically close HPV types, we design a triple-type chimera of HPV33/58/52 using loop swapping. The chimeric VLPs elicit neutralization titers comparable with a mix of the three wild-type VLPs both in mice and non-human primates. This engineered region of the chimeric protein recapitulates the conformational contours of the antigenic surfaces of the parental-type proteins, offering a basis for this high immunity. Our stratagem is equally successful in developing other triplet-type chimeras (HPV16/35/31, HPV56/66/53, HPV39/68/70, HPV18/45/59), paving the way for the development of an improved HPV prophylactic vaccine against all carcinogenic HPV strains. This technique may also be extrapolated to other microbes.


Subject(s)
Drug Design , Papillomaviridae/immunology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/immunology , Uterine Cervical Neoplasms/prevention & control , Animals , Antibodies, Viral/genetics , Antibodies, Viral/immunology , Capsid Proteins/genetics , Capsid Proteins/immunology , Drug Evaluation, Preclinical , Epitopes/genetics , Epitopes/immunology , Female , Genetic Engineering/methods , Immunogenicity, Vaccine , Macaca fascicularis , Male , Mice , Mice, Inbred BALB C , Models, Animal , Neutralization Tests , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/immunology , Papillomaviridae/genetics , Papillomavirus Infections/immunology , Papillomavirus Infections/virology , Papillomavirus Vaccines/genetics , Phylogeny , Specific Pathogen-Free Organisms , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/virology
8.
Emerg Microbes Infect ; 7(1): 160, 2018 Sep 26.
Article in English | MEDLINE | ID: mdl-30254257

ABSTRACT

Human papillomavirus (HPV) is the causative agent in genital warts and nearly all cervical, anogenital, and oropharyngeal cancers. Nine HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58) are associated with about 90% of cervical cancers and 90% of genital warts. HPV neutralization by vaccine-elicited neutralizing antibodies can block viral infection and prevent HPV-associated diseases. However, there is only one commercially available HPV vaccine, Gardasil 9, produced from Saccharomyces cerevisiae that covers all nine types, raising the need for microbial production of broad-spectrum HPV vaccines. Here, we investigated whether N-terminal truncations of the major HPV capsid proteins L1, improve their soluble expression in Escherichia coli. We found that N-terminal truncations promoted the soluble expression of HPV 33 (truncated by 10 amino acids [aa]), 52 (15 aa), and 58 (10 aa). The resultant HPV L1 proteins were purified in pentamer form and extensively characterized with biochemical, biophysical, and immunochemical methods. The pentamers self-assembled into virus-like particles (VLPs) in vitro, and 3D cryo-EM reconstructions revealed that all formed T = 7 icosahedral particles having 50-60-nm diameters. Moreover, we formulated a nine-valent HPV vaccine candidate with aluminum adjuvant and L1 VLPs from four genotypes used in this study and five from previous work. Immunogenicity assays in mice and non-human primates indicated that this HPV nine-valent vaccine candidate elicits neutralizing antibody titers comparable to those induced by Gardasil 9. Our study provides a method for producing a nine-valent HPV vaccine in E. coli and may inform strategies for the soluble expression of other vaccine candidates.


Subject(s)
Capsid Proteins/chemistry , Capsid Proteins/genetics , Escherichia coli/genetics , Oncogene Proteins, Viral/chemistry , Oncogene Proteins, Viral/genetics , Papillomaviridae/genetics , Papillomavirus Infections/virology , Amino Acid Motifs , Animals , Antibodies, Viral/immunology , Capsid Proteins/administration & dosage , Capsid Proteins/immunology , Escherichia coli/metabolism , Female , Gene Expression , Humans , Mice , Mice, Inbred C57BL , Oncogene Proteins, Viral/administration & dosage , Oncogene Proteins, Viral/immunology , Papillomaviridae/chemistry , Papillomaviridae/immunology , Papillomavirus Infections/immunology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Papillomavirus Vaccines/chemistry , Papillomavirus Vaccines/genetics , Papillomavirus Vaccines/immunology , Sequence Deletion
SELECTION OF CITATIONS
SEARCH DETAIL